Episode 341: PREMIUM - Evolocumab and what it does to cardiovascular outcomes
Submitted by JPM on Fri, 2017-03-17 14:41.
In episode 341, James and Mike talk about the long awaited trial of evolocumab that evaluated the impact it has on cardiovascular outcomes. Certainly not a homerun - maybe a very expensive full swing bunt with an error that leads to a single.
Show notes
1) Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease